Effective prophylaxis of vertical HIV transmission despite late diagnosis of the mother’s infection
More details
Hide details
Department of Pediatric Infectious Diseases and Hepatology, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University in Toruń, Provincial Hospital of Infectious Diseases, Bydgoszcz, Poland
Submission date: 2019-03-17
Final revision date: 2019-04-25
Acceptance date: 2019-04-26
Publication date: 2019-04-20
HIV & AIDS Review 2019;18(3):228-231
A newborn male born was admitted on the second day of life to the paediatric ward of the Provincial Observation and Infectious Hospital suspected of vertical human immunodeficiency virus (HIV) infection. In the mother's study, on the day of delivery, HIV markers were detected, which were confirmed on the following day by Western blotting. In the first day of life, the child was vaccinated against tuberculosis and hepatitis B. Before entering the infectious hospital ward, the newborn was breastfed several times until the second day of life. Laboratory tests showed elevated total bilirubin (6.82 mg/dl) with unincorporated bilirubin predominance (6.4 mg/dl). The viraemia of HIV RNA, which was undetectable, was evaluated by PCR. In accordance with the recommendations of the Polish AIDS Scientific Society, the newborn used triple antiretroviral therapy (ARV): zidovudine (ZDV), lamivudine (3TC), and nevirapine (NVP) in the following doses: ZDV – 2 × 14 mg for each day, 3TC – 2 × 7 mg for each day, and NVP – 2 × 7 mg. Treatment with ZDV and 3TC was continued for four weeks, and NVP for the first two weeks of therapy. In the presented case, during the three- and six-month follow-up visits HIV viral RNA was undetectable, the CD4+ cell amount was normal, and there were no deviations in psychomotor development, indicating that the prophylaxis of vertical HIV was effective.
Official website Polish AIDS Society. Available at: (Accessed: 06.02.2019).
Redmond AM, McNamara JF. The road to eliminate mother-to-child HIV transmission. J Pediatr (Rio J) 2015; 91: 509-511.
Marczyńska M, Popieliska J, Ołdakowska A, et al. Zakażenie HIV u dzieci. In: Horban A, Podlasin R, Cholewińska G, et al. (eds.). Zasady opieki nad osobami zakażonymi HIV. Zalecenia PTN AIDS, Waszawa 2017; 114-134.
EACS Guidelines Version 8,1 October 2016; 13.
Vocks- Hauck M. HIV and Pregnancy. Therapy for mother and prophylaxis for neonates. In: Hoffmann C, Rockstroh JK (eds.). HIV 2015/2016. Medizin Fokus Verlag, Hamburg 2015/2016; 531-546.
Jankowska M, Lemańska M. Profilaktyka transmisji wertykalnej HIV u ciężarnej. In: Horban A, Podlasin R, Cholewińska G, et al. (eds.). Zasady opieki nad osobami zakażonymi HIV. Zalecenia PTN AIDS, Warszawa 2017; 48-54.
Niemiec T, Kotarski J, Radowicki S, et al. Rekomendacje Zespołu Ekspertów PTG w zakresie zapobiegania perinatalnej transmisji HIV. Ginekol Pol 2009; 80: 59-62.
Helwich E, Marczyńska M, et al. Zapobieganie zakażeniom HIV u noworodków. In: Adamska E, Bekiesińska-Figatowska M, Błaż W, et al. Standardy opieki medycznej nad noworodkiem w Polsce. Zalecenia Polskiego Towarzystwa Neonatologicznego. Wydanie II. Media-Press Sp. z o.o., Warszawa 2017; 246-250.
Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Last updated: November 27, 2017. Available at: tentfiles/lvguidelines/pediatricguidelines.pdf.
Pulik P, Horban A. Leczenie antyretrowirusowe – monitorowanie i rozpoznanie leczenia antyretrowirusowego. In: Horban A, Podlasin R, Cholewińska G, et al. (eds.). Zasady opieki nad osobami zakażonymi HIV. Zalecenia PTN AIDS, Warszawa 2017; 69-73.
Journals System - logo
Scroll to top